Hepion Pharmaceuticals, Inc.
HEPA
$0.06
-$0.03-35.23%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.25M | -810.80K | -656.90K | -472.50K | -1.04M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.00K | 10.20K | 34.60K | -47.30K | -295.30K |
| Change in Net Operating Assets | -188.70K | 1.38M | 289.50K | 73.80K | -37.50K |
| Cash from Operations | -1.39M | 578.60K | -332.80K | -446.00K | -1.38M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | -132.10K |
| Cash from Investing | -- | -- | 0.00 | 0.00 | -132.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -54.10K | -160.20K | -157.40K | -154.50K |
| Issuance of Common Stock | 450.00K | 250.00K | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -30.00K | -- | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 420.00K | 195.90K | -160.20K | -157.40K | -154.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -974.00K | 774.50K | -493.00K | -603.30K | -1.66M |